UPDATE 1-Boston Scientific 3rd-qtr profit up on heart device sales

Oct 22 (Reuters) - Boston Scientific Corp on Wednesday posted third-quarter profit in line with analysts' expectations on increased sales of its implantable heart devices, and raised its full-year outlook for revenue and profit, excluding items.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.